Edison Investment Research - JDC Group AG (JDC) JDC Group - 2024 could turn out to be a very strong year

Report

Edison Investment Research

Pedro Fonseca

JDC Group - 2024 could turn out to be a very strong year

JDC reported preliminary FY23 results that were broadly in line with estimates, implying an impressive EBITDA generation of €5m in Q4. JDC guides for FY24 revenue growth acceleration to 24% at the midpoint of guidance (€205–220m), compared to 10% revenue growth in 2023. This still seems conservative given the tailwinds from the market environment and the acquisition of Top Ten Financial Network, which will add around 10% of revenue growth alone. The EBITDA margin is also expected to increase based on a guided EBITDA range of €14.5–16.0m

11/03/2024 1 EN

Underlying

JDC Group AG

JDC Group AG. JDC Group AG, formerly Aragon AG, is a Germany-based financial services company that offers brokerage financial products and consultancy services. The Company's business is divided into two business segments: Advisory and AdvisorTech. The Advisory segment provides financial products of its subsidiaries Jung, DMS & Cie. and FiNUM to end customers via independent consultants, brokers and financial service providers. In addition, this segment also operates a managed portfolio of investment funds, closed-end funds, certificates, insurance policies and other financial products. The AdvisorTech segment provides information technology (IT) and management consulting services. The Company is active in Germany and Austria. JDC Group AG operates Jung, DMS & Cie, FiNUM. Private Finance AG (Austria), FiNUM Private Finance AG (Germany) and FiNUM. Finanzhaus AG as subsidiaries.

See profile

DE000A0B9N37 Germany

Provider

Edison Investment Research

Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

See profile

Analysts

Pedro Fonseca

Other Reports on these Companies

Edison Investment Research

JDC Group - Accelerating again in FY24

JDC Group (JDC) reported FY23 results that were in line with the preliminary results published on 8 March. After a very strong Q423, JDC expects FY24 revenue growth to accelerate to c 17% (FY23: 10.0%) and EBITDA to grow by 36% (FY23: 30.2%) at the midpoint of guidance. To reach the FY25 target of €246m in revenue, JDC also needs 17% top-line growth in FY25. JDC trades at an FY25e EV/EBITDA multiple of 13.7x on our estimates, which we believe is undemanding for what is essentially a fast-scaling platform business. Our DCF provides a valuation of €34.04/share (versus €34.09/share previously).

April 8, 2024 April 8, 2024 1 EN

EQS Group AG

EQS-News: JDC Group AG bestätigt vorläufige Zahlen 2023

EQS-News: JDC Group AG / Schlagwort(e): Jahresbericht JDC Group AG bestätigt vorläufige Zahlen 2023 28.03.2024 / 08:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. JDC Group AG bestätigt vorläufige Zahlen 2023 Umsatz 2023 wächst um 10 Prozent auf 171,7 Mio. EUR EBITDA steigt um rund 31 Prozent auf 11,7 Mio. EUR nach 9,0 Mio. EUR im Vorjahr Für 2024 wird eine deutliche Umsatz- und Gewinnsteigerung erwartet Die JDC Group AG (ISIN DE000A0B9N37) hat ihre Finanzzahlen 2023 veröffentlicht und bestätigt damit die am 8. März ver...

March 28, 2024 March 28, 2024 1 DE

EQS Group AG

EQS-News: JDC Group AG confirms preliminary figures for 2023

EQS-News: JDC Group AG / Key word(s): Annual Report JDC Group AG confirms preliminary figures for 2023 28.03.2024 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. JDC Group AG confirms preliminary figures for 2023 Revenues in 2023 grow by 10 percent to EUR 171.7 million EBITDA increases by around 31% to EUR 11.7 million after EUR 9.0 million in the previous year Significant revenue and earnings growth expected for 2024 JDC Group AG (ISIN DE000A0B9N37) has published its financial figures for 2023, confirming the preliminary ...

March 28, 2024 March 28, 2024 1 EN

BlackRock Sustainable American Income Trust - Unique value/ESG fund at an attractive valuation

BlackRock Sustainable American Income Trust (BRSA) offers a unique opportunity to invest in a fund that focuses on both value and sustainability. The trust’s three managers, Tony DeSpirito, David Zhao and Lisa Yang, aim to deliver an attractive level of income and long-term capital growth from a portfolio of attractively valued, high-quality, dividend-paying companies, which have favourable ESG credentials either as leaders, improvers or ‘sustainability enablers’. BRSA’s managers are finding attractive opportunities due to the historically wide valuation gap between value stocks and the broad ...

3h / 35m 3h / 35m 1 EN

Richard Williamson

Richard Williamson

Northern Data Group - Continued progress as a diversified HPC provider

Northern Data Group demonstrated progress made in Q124 alongside a capital markets day update, as it takes further steps in becoming a diversified high-performance computing (HPC) infrastructure solutions provider. It expects to deploy 20,000 NVIDIA H100 graphic processing units in FY24, cementing its position as Europe’s foremost AI hardware cluster. Key to this, 85% of its H100 capacity has already been sold. Management’s ambitious guidance is unchanged, expecting revenue of €200–240m in FY24 and €520–570m in FY25, with adjusted EBITDA growing from €50–80m in FY24 to €300–350m in FY25. The s...

21h / 11m 21h / 11m 1 EN

Sean Conroy

Sean Conroy

Oryzon Genomics - Doubling down on clinical activity in 2024

Oryzon’s Q124 results emphasised the company’s focus on advancing and expanding its CNS and oncology pipelines, driven by its core assets, vafidemstat and iadademstat. Operating performance was in line, with the lower opex (37% y-o-y decline to €3.2m) driven by reduced R&D spending following completion of the Phase IIb PORTICO trial. Notwithstanding the mixed PORTICO results in borderline personality disorder (BPD), we expect clinical activity to pick up in the coming months, with the initiation of the iadademstat combination studies in first-line AML (Phase Ib) and SCLC (Phase Ib/II) in Q224,...

21h / 25m 21h / 25m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

JDC Group - 2024 could turn out to be a very strong year

JDC Group - Accelerating again in FY24

EQS-News: JDC Group AG bestätigt vorläufige Zahlen 2023

EQS-News: JDC Group AG confirms preliminary figures for 2023

BlackRock Sustainable American Income Trust - Unique value/ESG fund at an attractive valuation

Northern Data Group - Continued progress as a diversified HPC provider

Oryzon Genomics - Doubling down on clinical activity in 2024

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe